enow.com Web Search

Search results

    15.49+0.17 (+1.11%)

    at Wed, Jun 5, 2024, 12:44PM EDT - U.S. markets close in 3 hours 15 minutes

    Nasdaq Real Time Price

    • Open 15.35
    • High 15.52
    • Low 15.22
    • Prev. Close 15.32
    • 52 Wk. High 27.02
    • 52 Wk. Low 13.71
    • P/E N/A
    • Mkt. Cap 1.22B
  1. Results from the WOW.Com Content Network
  2. Retinal implant - Wikipedia

    en.wikipedia.org/wiki/Retinal_implant

    A retinal implant is a visual prosthesis for restoration of sight to patients blinded by retinal degeneration. The system is meant to partially restore useful vision to those who have lost their photoreceptors due to retinal diseases such as retinitis pigmentosa (RP) or age-related macular degeneration (AMD).

  3. FDA Approves Biosimilars for Macular Degeneration Treatment - AOL

    www.aol.com/fda-approves-biosimilars-macular...

    The FDA approved two biosimilars for Eylea (aflibercept), a drug used to treat age-related macular degeneration, diabetic retinopathy and other eye conditions. Biosimilars Yesafili and Opuviz...

  4. Visual prosthesis - Wikipedia

    en.wikipedia.org/wiki/Visual_prosthesis

    A visual prosthesis, often referred to as a bionic eye, is an experimental visual device intended to restore functional vision in those with partial or total blindness. Many devices have been developed, usually modeled on the cochlear implant or bionic ear devices, a type of neural prosthesis in use since the mid-1980s.

  5. Metamorphopsia - Wikipedia

    en.wikipedia.org/wiki/Metamorphopsia

    Metamorphopsia can be a symptom of a number of eye disorders involving the retina or macula. Some of these conditions include the following: Age-related macular degeneration; Epiretinal membrane and vitreomacular traction; Posterior vitreous detachment; Macular hole; Diagnosis

  6. Merck to buy eye-focused drug developer EyeBio for as ... - AOL

    www.aol.com/merck-acquire-eye-drug-company...

    (Reuters) -Merck on Wednesday agreed to buy privately held biotech EyeBio for as much as $3 billion, as it looks to diversify its portfolio of experimental drugs with treatments for eye diseases.

  7. How to reduce risks of macular degeneration - AOL

    www.aol.com/lifestyle/actress-judi-dench-says...

    Macular degeneration happens with age, when the macula, at the center of the retina — “the part of the eye that sees the world for us,” Dr. Vlad Diaconita, a retinal and vitreoretinal ...

  8. Macular degeneration - Wikipedia

    en.wikipedia.org/wiki/Macular_degeneration

    8.7% global prevalence in 2020 [2] Macular degeneration, also known as age-related macular degeneration ( AMD or ARMD ), is a medical condition which may result in blurred or no vision in the center of the visual field. [1] Early on there are often no symptoms. [1] Over time, however, some people experience a gradual worsening of vision that ...

  9. Convergence insufficiency - Wikipedia

    en.wikipedia.org/wiki/Convergence_insufficiency

    Convergence insufficiency. Convergence Insufficiency. Other names. Convergence disorder. Specialty. Ophthalmology, optometry. Convergence insufficiency is a sensory and neuromuscular anomaly of the binocular vision system, characterized by a reduced ability of the eyes to turn towards each other, or sustain convergence .

  10. AMD Alliance International - Wikipedia

    en.wikipedia.org/wiki/AMD_Alliance_International

    AMD is an eye condition that causes loss of central vision, leaving only peripheral, or side, vision intact. AMD is the leading cause of visual impairment for people over 50 in the Western world. Types & Detection. Macular degeneration is often related to aging, thus the name age-related macular degeneration (AMD or ARMD).

  11. Stem cell therapy for macular degeneration - Wikipedia

    en.wikipedia.org/wiki/Stem_cell_therapy_for...

    Stem cell therapy for macular degeneration is the use of stem cells to heal, replace dead or damaged cells of the macula in the retina. Stem cell based therapies using bone marrow stem cells as well as retinal pigment epithelial transplantation are being studied. [1]